|
OPA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.602280E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.015110E-04 |
| Normal-vs-Stage2 |
2.007400E-01 |
| Normal-vs-Stage3 |
4.279400E-03 |
| Normal-vs-Stage4 |
5.089800E-02 |
| Stage1-vs-Stage2 |
4.916800E-01 |
| Stage1-vs-Stage3 |
9.068000E-01 |
| Stage1-vs-Stage4 |
7.573000E-01 |
| Stage2-vs-Stage3 |
4.898000E-01 |
| Stage2-vs-Stage4 |
5.006800E-01 |
| Stage3-vs-Stage4 |
8.025200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.99460000000129E-05 |
| Normal-vs-AfricanAmerican |
4.238400E-02 |
| Normal-vs-Asian |
2.737200E-01 |
| Caucasian-vs-AfricanAmerican |
2.585600E-01 |
| Caucasian-vs-Asian |
9.667000E-01 |
| AfricanAmerican-vs-Asian |
6.820600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.47120000004719E-06 |
| Normal-vs-Female |
6.540600E-01 |
| Male-vs-Female |
1.163860E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.918060E-02 |
| Normal-vs-Extreme_Weight |
6.390800000311E-07 |
| Normal-vs-Obese |
2.978400E-03 |
| Normal-vs-Extreme_Obese |
6.506200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.922000E-01 |
| Normal_Weight-vs-Obese |
8.830800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.215200E-01 |
| Extreme_Weight-vs-Obese |
1.049650E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.051400E-01 |
| Obese-vs-Extreme_Obese |
6.051600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.043900E-02 |
| Normal-vs-Age(41-60Yrs) |
7.180800E-03 |
| Normal-vs-Age(61-80Yrs) |
6.32229999999456E-05 |
| Normal-vs-Age(81-100Yrs) |
2.114200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.257400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.837400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.111400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.316620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.890000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.553200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.15659999999574E-05 |
| Normal-VS-Type2 PRCC |
1.103930E-02 |
| Normal-VS-KIRP CIMP |
3.184400E-01 |
| Normal-VS-Unclassified PRCC |
1.509640E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.975600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.149600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.309600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.311200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.372200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.656000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.27849999997931E-06 |
| Normal-vs-N1 |
1.187900E-02 |
| Normal-vs-N2 |
7.250800E-01 |
| N0-vs-N1 |
2.269800E-01 |
| N0-vs-N2 |
6.354800E-01 |
| N1-vs-N2 |
8.374200E-01 |
|
|
